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Murine splenic stroma has been found to provide an in vitro niche for hematopoiesis of
dendritic-like APC. Two distinct cell types have been characterized. The novel “L-DC” sub-
set has cross-presenting capacity, leading to activation of CD8+ T cells, but not activating
CD4+ T cells, which is consistent with their CD11cloCD11bhiMHC-II− phenotype. For L-DC,
an equivalent tissue-specific APC has been found only in spleen. A second population of
CD11chiCD11bloMHC-II+ cells resembling conventional dendritic cells (cDC) can activate
both CD4 and CD8 T cells. Production of L-DC but not cDC-like cells is now shown to be
dependent on contact between the L-DC progenitor and stroma such that the presence of
aTranswell membrane can prevent L-DC development. Since L-DC can be produced contin-
uously in vitro in stromal co-cultures overlaid with bone marrow (BM) progenitors, it was
hypothesized that L-DC progenitors are self-renewing. The L-DC progenitor is shown here
to be defined by the Flt3−c-kit+Lin−Sca-1+ (F−KLS) subset of adult BM which contains
primitive HSC. Since the less primitive F+KLS HSC subset also contains L-DC progenitors,
Flt3 does not appear to be a defining marker for this progenitor. Precursors of the cDC-like
subset are found only within the F+KLS subset and seed production of a transient popu-
lation of APC. All data identify differentiation of L-DC from HSC, and of cDC-like cells from
DC precursors, which occurs independently of inflammatory signals and is dependent on
a splenic stromal microenvironment.
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INTRODUCTION
A novel dendritic-like cell type has been described in spleen,
namely “L-DC” (O’Neill et al., 2011; Tan et al., 2011). Studies
to identify a progenitor of L-DC have revealed a subset of lin-
eage (Lin)−c-kitlo cells in adult and neonatal spleen reflecting
hematopoietic stem/progenitor cells (HSPC) (Tan et al., 2010; Tan
and O’Neill, 2012; Periasamy et al., 2013). L-DC progenitors also
exist in bone marrow (BM) (Periasamy et al., 2009; Periasamy
and O’Neill, 2013) and fetal liver (Hinton et al., 2011). When
BM depleted of Lin+ cells is co-cultured above the 5G3 splenic
stromal line, the phenotypically distinct CD11cloCD11bhiMHC-
II−CD8α− subset of L-DC is produced continuously, along with
a transient population of CD11chiCD11bloMHC-II+CD8α− cells
resembling conventional dendritic cell (cDC) (Periasamy et al.,
2009; Periasamy and O’Neill, 2013). The latter have been shown
to reflect a distinct APC type, which are not developmentally
linked with L-DC (Periasamy and O’Neill, 2013). The latter cells
are thought to arise from preformed DC precursors present in
BM and spleen which have limited replicative capacity when
cultured over 5G3 stroma. The L-DC subset is phenotypically dis-
tinct from known subsets of plasmacytoid (p) DC and CD8α+
and CD8α− subsets of cDC described in spleen (Wu and Liu,
2007), which have also been shown to arise in vitro from Flt3L
supplemented cultures of fractionated BM (Naik et al., 2005).
Since L-DC production is sustained for long periods in splenic
stromal co-cultures, the question arises as to whether the L-DC
progenitor reflects a self-renewing stem cell. One explanation is
that hematopoietic stem cells (HSC) are maintained in vitro in
contact with 5G3 stroma, and undergo restricted differentiation
with long-term (LT) production of L-DC. This would suggest
maintenance of HSC in vitro, which was not readily achievable
in the past. Here we have tested the hypothesis that HSC in BM
can undergo differentiation to produce L-DC, and conclude that
this happens but only when HSC maintain contact with splenic
stroma. The 5G3 splenic stromal cell line has been employed as
an in vitro niche, and its ability to support HSC maintenance
and myelopoiesis tested by flow cytometric analysis of cells pro-
duced over time. HSC in murine BM are commonly identified as
Lin−c-kit+Sca-1+ (KLS) cells (Spangrude et al., 1988) reflecting
a heterogeneous subset (Kondo et al., 2003; Papathanasiou et al.,
2009). Different HSC subsets can be distinguished as short-term
(ST) or LT based on the extent of their potential to reconstitute
an irradiated host (Weissman, 2000). The Flt3(F)−KLS subset of
BM contains a majority of LT-HSC, and the F+KLS subset con-
tains ST-HSC (Lai et al., 2005), although a minor CD34+ subset
of F−KLS cells also has ST reconstitution capacity (Yang et al.,
2005). Here BM-derived HSC, as the F−KLS and F+KLS subsets,
have been compared for capacity to seed 5G3 co-cultures for L-
DC production under different conditions. Since hematopoiesis
involving BM-derived HSC can be induced in response to toll-
like receptor (TLR) 2/4 stimulation by infectious agents (Kincade,
2006; Nagai et al., 2006), the role of inflammatory signaling in
L-DC development was also investigated using knockout mouse
strains.
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MATERIALS AND METHODS
ANIMALS
Specific pathogen-free C57BL/6J (H-2Kb), C57BL/6.Rag1−/−,
C57BL/6.Tg(TcraTcrb)1100Mjb (OT-I), and C57BL/6.SJL/J.OT-
II.CD45.1 (OT-II) mice aged 6–8 weeks were purchased from
the John Curtin School of Medical Research (JCSMR: Can-
berra, ACT, Australia). C57BL/6.MyD88−/−, C57BL/6.TRIF−/−,
and C57BL/6.MyD88−/−TRIF−/− mice were purchased from the
Walter and Eliza Hall Institute (Melbourne, VIC, Australia). Mice
were housed and handled according to protocols approved by
the Animal Experimentation Ethics Committee at the Australian
National University (Canberra, ACT, Australia). BM and spleen
cells were dissociated by forcing tissue through a fine wire sieve, fol-
lowed by lysis of red blood cells as described previously (Periasamy
et al., 2009).
CELL FRACTIONATION
Lin− BM was prepared by depleting BM of hematopoietic lineage
cells. Biotin-labeled antibodies specific for CD5, CD45R, CD11b,
Gr-1 (Ly-6G/C), 7-4, and Ter-119 (Lineage Depletion kit, Miltenyi
Biotec: North Ryde, NSW, Australia) along with added antibody
specific to CD11c, were absorbed to cells according to manufac-
turer’s protocol. Following antibody binding, MACS® anti-biotin
microbeads (Miltenyi Biotec) were added, cells transferred to a
MACS® MS column (Miltenyi Biotec) which was placed in the per-
manent magnet of a SuperMACS® II Separator (Miltenyi Biotec).
Cells binding the superparamagnetic anti-biotin microbeads are
retained in the MACS® MS column (Miltenyi Biotec). Flow-
through cells were collected after washing with buffer. An aliquot
of the Lin− cell population was tested by flow cytometry for the
presence of Lin+ cells to determine the efficiency of depletion.
T cells were purified from spleen by depletion of macrophages,
B cells, and MHC-II+ APC using specific antibodies and anti-Ig
Dynabeads® (Invitrogen Dynal: AS, Oslo, Norway) as described
previously (Tan et al., 2010). Antibodies were specific for CD11b
(clone M1/70), B220 (clone RA3-6B3), and IAb/k (clone TIB120)
(eBiosciences). For depletion of CD4+ or CD8+ T cells, either
anti-CD4 (GK1.5) or anti-CD8 (53-6.7) was included in the anti-
body cocktail (eBiosciences: San Diego, CA, USA). Fractionated T
cells were labeled with carboxyfluorescein diacetate succinimidyl
ester (CFSE) for flow cytometric analysis of their proliferation as
described previously (Tan et al., 2010). CFSE (Molecular Probes:
Eugene, OR, USA) was added to cells to a final concentration of
10µg/ml, samples vortexed immediately, and then incubated at
room temperature for 5 min. Cells were washed twice before use.
Splenic CD11c+ DC were freshly isolated as control APC using
anti-CD11c magnetic MACS® microbeads (Miltenyi) as described
previously (Tan et al., 2010). The cell suspension was run into
MACS® MS column, and the column washed to deplete unbound
cells. After the final wash, the column was removed from the
SuperMACS® (Miltenyi) magnet and placed over a fresh tube for
elution of CD11c+ labeled cells.
CELL CULTURE
The cloned 5G3 stromal line which supports in vitro
hematopoiesis, and conditions for culture have been described
previously (Despars and O’Neill, 2006; Periasamy et al., 2009).
5G3 was maintained by scraping attached cells for passage into a
new flask. In order to maintain the stability of this cloned line,
frozen stocks were established and cell cultures discarded after five
passages. In controlled co-culture experiments, stromal cells were
dissociated and harvested using 0.25% trypsin-EDTA treatment
before plating a given number of cells.
FLOW CYTOMETRY AND CELL SORTING
Fluorochrome-labeled antibodies specific for cell surface mark-
ers were purchased from either Biolegend (San Gabriel, CA,
USA) or eBiosciences; c-kit (CD117), Sca-1 (D7), Flt3 (A2F10),
CD69 (H12F3), CD11b (M1/70), CD11c (N418), I-Ab (MHC-
II) (AF6-120.1), CD115 (AF598), Sirpα (P84), TCR-Vα2 (B20.1),
and Thy1.2 (30-H12). These were used at minimal saturating
concentration in multi-color staining experiments according to
previously described methods for staining and washing of labeled
cells (Periasamy et al., 2009; Tan et al., 2010).“Fc block”specific for
FcγII/IIIR (CD32/CD16) (eBiosciences) was used to block non-
specific binding of antibody. In all experiments, propidium iodide
(PI) at 1µgm/ml was added to cells for flow cytometric discrim-
ination of dead cells. For multi-color staining, multiple primary
antibodies were added together in the first staining step. The speci-
ficity of antibody binding was monitored through use of isotype
control antibodies.
Flow cytometry was performed on an LSRII FACS machine
(Becton Dickinson: Franklin Lakes, NJ, USA). FACSDIVA soft-
ware (Becton Dickinson) was used to set voltage parameters and
event counts while running samples. For multi-color analysis, sin-
gle color compensation controls were used to set compensation
on the machine. FlowJo software (FlowJo: Ashland, OR, USA)
was used to analyze data. Commonly, cell debris was gated out
using a forward scatter (FSC) threshold of 100. Cells were fur-
ther gated on the basis of side scatter (SSC) and absence of PI
staining to detect “live PI−” cells. Post-acquisition gating was used
to obtain information on cell subsets, and staining with isotype
controls was used to set gates to distinguish specific antibody
staining.
Cell sorting was used to isolate hematopoietic cell subsets
based on expression of Sca-1, c-kit, and Flt3. BM cells were
stained with antibodies and the Lineage Depletion cocktail of
biotinylated antibodies followed by a secondary fluorochrome-
conjugated streptavidin conjugate (Miltenyi Biotec) for exclusion
of mature hematopoietic cells. Sorting was performed on a BD
FACSAria™ II cell sorter (Becton Dickinson).
Endocytosis was measured flow cytometrically to assess capac-
ity of cells to take up antigen by addition of 100µg/ml OVA-FITC
(Molecular Probes) in a total volume of 100µl sDMEM. Cells
were incubated at 37˚C for 45 min before endocytosis was halted
by addition of 100µl chilled PBS/0.1% NaN3. Cells were washed
three times before analysis by flow cytometry.
ESTABLISHMENT OF CO-CULTURES
The capacity of 5G3 to support hematopoiesis was assessed by
overlay of Lin− BM or HSC sorted from BM above stromal mono-
layers followed by co-culture for several weeks. This procedure has
been described previously (Periasamy et al., 2009; Tan et al., 2010).
Stromal cell lines were grown to 80–90% confluency, and Lin− BM
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or HSC were plated at 1–5× 104 cells/ml above stromal monolay-
ers. At 7-day intervals, non-adherent cells were collected by gently
shaking the flask, with removal and replacement of supernatant.
T CELL ACTIVATION ASSAYS
The antigen processing capacity of co-culture produced APC
was measured by the ability of antigen-pulsed cells to induce
proliferation of CD8+ T cells purified from spleens of OT-I
TCR-Transgenic (Tg) mice specific for OVA257-264/H-2Kb. The
ability of isolated co-culture produced APC subsets to present
antigen to CD4+ T cells similarly was measured using OT-II
TCR-Tg mice specific for OVA323-339/H-2IAb. APC were pulsed
with 10µg/ml of OVA or control antigen HEL overnight (8–
12 h), then washed twice by centrifugation. Some cultures were
given lipopolysaccharide (LPS) as a potential activator (10µg/ml)
for 8–12 h.
CFSE-labeled T cells were cultured at 2× 105 cells per well in
a 96-well plate together with graded numbers of APC, or alone as
a control. Cells were plated in a total volume of 200µl sDMEM,
and plates incubated at 37˚C for either 12 h or 4 days. T cells were
identified by labeling for CD11c, TCR-Vα2, Thy1.2, and either
CD4 or CD8. At 24 h, cells were also stained for CD69 expression
to determine activation. At 4 days, CFSE staining was assessed as
an indicator of cell proliferation. Cell division was assessed flow
cytometrically in terms of reduction in CFSE level as T cells divide.
MICROSCOPY
A DM IRE2 inverted research microscope (Leica) equipped with
DFC digital camera (Leica) was used to obtain phase con-
trast photomicrographs. Images were processed using Leica IM
software v4.0.
STATISTICAL ANALYSIS
Student’s two-tailed t -test was used to test significance (p≤ 0.05).
RESULTS
STROMAL CELL CONTACT INFLUENCES MYELOPOIESIS IN
CO-CULTURES
Co-cultures of Lin− BM over 5G3 stroma were established in the
presence and absence of a Transwell membrane which prevents
stromal contact with overlay cells. This barrier membrane enables
assessment of the role of soluble factors in hematopoiesis in the
absence of cell contact. Production of myeloid and dendritic cells
was monitored by staining for CD11c, CD11b and MHC-II. Across
42 day co-cultures, cell production varied between co-cultures
with and without Transwells. In the presence of a Transwell, almost
all cells produced across 42 days were CD11c+CD11b+MHC-II+
cDC-like cells (Figure 1). These have been termed “Transwell”
DC or “T-DC.” In co-cultures without a Transwell membrane,
cell production across 14, 28, and 42 days involved an increas-
ing proportion of CD11cloCD11bhiMHC-II− L-DC (Figure 1),
with reducing numbers of CD11chiCD11bloMHC-II+ cDC-like
cells as described previously (Periasamy et al., 2009). This result
verifies the importance of progenitor contact with stroma for
CD11c+CD11b+MHC-II− L-DC production. A minor subset of
CD11c-CD11b+MHC-II− myeloid-like cells was detected early in
co-cultures, suggesting that these cells developed from existing
precursors in a contact-independent manner.
FIGURE 1 | Importance of stromal cell contact for L-DC development.
Co-cultures were established in three replicate experiments by overlay of
Lin− BM over near-confluent 5G3 stroma with or without a Transwell
membrane for a period of up to 42 days. Non-adherent cells were collected
at 7-day intervals and assessed in terms of cell surface phenotype. (A) Cells
were stained with fluorochrome-conjugated antibodies specific for CD11c,
CD11b, and MHC-II, or with isotype control antibodies. FSC and SSC
analysis was used to gate large (FSChi) cells (not shown) for subsequent
multichannel analysis. Isotype controls were used to set gates indicating
background antibody binding. Numbers shown in quadrants represent %
positive cells. Data shown reflect one representative experiment out of
three. (B) The relative proportion of MHC-II− and MHC-II+ cells amongst
CD11c+CD11b+ cells produced in co-cultures was estimated. Data
represent mean±SE (n=3 replicate experiments).
When overlay cells were in contact with stroma, an early popu-
lation of CD11c+CD11b+MHC-II+ cDC-like cells was observed,
representing ∼85% of all CD11c+CD11b+ cells at 7 days, but
reducing to only ∼10% by 42 days (Figure 1B). In contrast, the
CD11c+CD11b+MHC-II− L-DC population increased from∼15
to ∼87% over this time. The effect of Transwells was to reduce
overall cell production, as well as specifically exclude production
of L-DC. Lin− BM co-cultures showed peak cell production at
28 days, and this was significantly greater (p< 0.01, Wilcoxon
Rank Sum Test) than cell production in Transwell co-cultures
(data not shown). These experiments emphasize the importance
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of stromal cell contact for L-DC production, and the role of soluble
factors in the development of cDC-like cells (T-DC).
Further evidence for production of 2 distinct cell types in
co-cultures of Lin− BM over 5G3 stroma was obtained when
cells were stained for Sirpα, a marker present on some subsets
of dendritic cells and on macrophages (Matozaki et al., 2009).
The CD11c+CD11b+MHC-II− subset of L-DC clearly expressed
Sirpα+, while the CD11c+CD11b+MHC-II+ cDC-like cells did
not (Figure 2A). Neither subset of cells expressed CD115 (M-
CSFR), which distinguishes them from potential precursors of
pDC and cDC in BM (Fancke et al., 2008). Following culture
of isolated cells with LPS for 24 h, there was no cell activation
evident by upregulation of MHC-II expression. However, the pro-
portion of live cDC-like cells was reduced suggesting that they may
have become activated and subsequently apoptotic following LPS
treatment (Figure 2A).
CO-CULTURES PRODUCE TWO SUBSETS OF FUNCTIONALLY
DISTINCT APC
Lin− BM co-cultures were established in the presence and absence
of a Transwell membrane. Non-adherent cells were collected after
28 days of co-culture, and dominant subsets purified by sorting. L-
DC were sorted as CD11c+CD11b+MHC-II− cells from stromal
contact co-cultures (no Transwell), and CD11c+CD11b+MHC-
II+ cDC-like cells were sorted as T-DC from Transwell co-cultures.
When these subsets were compared for endocytosis of FITC-OVA,
as a measure of soluble antigen uptake capacity, L-DC were notice-
ably more endocytic than T-DC, with 96% of cells endocytic,
compared with 45% for T-DC (Figure 2B).
Sorted L-DC and T-DC were then compared along with freshly
isolated CD11c+ spleen DC (f-DC) for ability to present exoge-
nous antigen to CD8+ T cells purified from OT-I TCR-Tg mice. All
three APC subsets were equally able to activate CD8+ OT-I T cells
in an antigen (OVA)-specific manner. This was evident by upreg-
ulation of CD69 expression on gated CD8+Vα2+Thy1.2+ T cells
at 24 h, both in the presence and absence of LPS (Figure 3A). After
4 days, all APC induced antigen-specific proliferation of CD8+
OT-I T cells measured in terms of percent cells showing reduc-
tion in CFSE, indicative of T cells which had divided at least once
(Figure 3B). The addition of LPS caused a noticeable, although
not significant, increase in CD8+ T cell proliferation at T cell:
APC ratios of 2:1 and 10:1 for all APC tested (Figure 3B). This
FIGURE 2 | Endocytic capacity of L-DC produced in co-cultures.
Co-cultures were established with Lin− BM over 5G3 stroma as in Figure 1
with or without Transwells. (A) Non-adherent cells collected at 28 days were
incubated for 24 h with and without LPS (10µg/ml) and cells then stained with
fluorochrome-conjugated CD11b, CD11c, MHC-II, Sirpα, and CD115
antibodies. Propidium iodide (PI; 1µg/ml) was added to allow gating of PI−
live cells. BM cells served as a positive control to set gates for CD115 staining
(data not shown). (B) Non-adherent cells collected at 28 days were also
stained with antibody and sorted to isolate the predominant subsets of
CD11b+CD11c+MHC-II+ cells (T-DC) produced in Transwell co-cultures (no
contact), and CD11b+CD11c+MHC-II− cells (L-DC) produced in normal
co-cultures (contact). Sorted cells were compared for capacity to endocytose
soluble antigen following incubation with FITC-conjugated ovalbumin
(FITC-OVA; 2 mg/ml) for 45 min at 37˚C, or at 4˚C as control. Uptake of
FITC-OVA was assessed flow cytometrically in terms of % endocytic cells.
Data represent mean±SE from three independent experiments. L-DC were
significantly more endocytic than T-DC (p≤0.05). (C) Co-cultures were
established with HSC (F−KLS and F+KLS) and Lin− BM, and sorted and
analyzed as in (B). L-DC were significantly more endocytic than T-DC in all
three co-cultures (p≤0.05).
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FIGURE 3 | Ability of L-DC andT-DC to activateT cells. L-DC and T-DC
produced in Lin− BM co-cultures were prepared by sorting as described in
Figure 2. They were compared for capacity to present soluble antigen
OVA, or control antigen HEL, in the presence and absence of LPS to CD8+
T cells from OT-I TCR-Tg mice specific for OVA257-264/H-2Kb (A,B) and to
CD4+ T cells from OT-II TCR-Tg mice specific for OVA323-339/H-2IAb (C,D).
Freshly isolated splenic DC (f-DC) from C57BL/6J (H-2b) mice were used
as an APC control. APC were pulsed for 12 h with OVA, HEL, OVA+LPS,
or HEL+ LPS. Diluting numbers of APC were co-cultured with different T
cell: APC ratios and with CFSE-labeled CD8+ or CD4+ T cells purified from
OT-I or OT-II spleens through depletion of B cells, myeloid cells, DC, and
CD4+ or CD8+ T cells. (A,C) T cell activation was analyzed after 24 h in
terms of % cells staining for CD69 in one of three replicate experiments.
(B,D) T cell proliferation was measured after 4 days in terms of % cells
showing a reduction in CFSE staining. T cells were gated as live (PI−)
CD11c−Thy1.2+Vα2+ cells which were CD4+ or CD8+ using flow cytometry.
Data represent mean±SE of three replicate experiments. T cell only
control (not shown) was <1%.
is consistent with the ability of LPS to upregulate MHC-I and
CD80/86 expression on L-DC (Hinton and O’Neill, 2012), an effect
also commonly described for cDC (Tan and O’Neill, 2005).
The ability of sorted L-DC and T-DC to present antigen to
CD4+ T cells via the endocytic MHC-II pathway was tested
using OT-II TCR-Tg mice. APC were pulsed with specific anti-
gen OVA (and control antigen HEL) in the presence and absence
of LPS. L-DC were unable to activate or stimulate proliferation of
CD4+ T cells (Figure 3) consistent with their absence of MHC-
II expression (Figure 2A). As expected, control f-DC showed
antigen-specific, LPS-responsive activation of CD4+ T cells at
12 h, and T cell proliferation at 4 days (Figure 3). This was sig-
nificantly enhanced by the presence of LPS at T cell: APC ratios of
2:1 and 10:1. While T-DC (cDC-like cells) were unable to stimu-
late CD4+ T cell proliferation after 4 days, although they did show
strong antigen-specific, LPS-responsive activation of CD4+ T cells
at 12 h. The restricted ability of T-DC, which are MHC-II+, to
activate CD4+ T cells without subsequent T cell proliferation sug-
gests inability of these cells to induce an immunogenic response.
MHC-II expression on L-DC cannot be induced by LPS treatment
(Hinton and O’Neill, 2012) in contrast to cDC where LPS causes
upregulation of MHC-II (Tan and O’Neill, 2005).
A PURIFIED HSC SUBSET CONTAINS L-DC PROGENITORS
Since stromal cell contact was required for L-DC production, the
possibility that L-DC progenitors are closely related to HSC was
considered. An HSC subset was prepared by sorting a Lin− sub-
set of BM following staining for lineage markers CD5, CD11b,
B220, Ly-6G/C, 7-4, and Ter-119, and the DC marker CD11c. Cells
were also stained for the hematopoietic progenitor markers c-kit,
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Sca-1, and Flt3 to gate two HSC subsets: Lin−CD11c−c-kit+Sca-
1+Flt3− (F-KLS) and Lin−CD11c−c-kit+Sca-1+Flt3+ (F+KLS)
(Figure 4A). Sorted F−KLS represented ∼0.035% and sorted
F+KLS∼0.025% of all BM cells (Figure 4B). These two HSC sub-
sets together with Lin− BM as a positive control, were then tested
for capacity to differentiate above 5G3 stroma in the presence and
absence of a Transwell membrane. Three replicate experiments
were established, and in each experiment, cells recovered from six
flasks were pooled for analysis.
Figure 4C depicts the development of non-adherent cells in
contact with the 5G3 stromal layer at 28 days in co-cultures estab-
lished with Lin− BM, and the F−KLS and F+KLS BM subsets.
Stroma only control cultures showed no foci of developing cells.
5G3 stroma supported hematopoiesis in all co-cultures studied
for 35 days. The cell yield relative to input cell number was cal-
culated for co-cultures established with and without stromal cell
contact. This reached a peak of ∼200% at 28 days for each of the
F−KLS, F+KLS, and Lin− BM co-cultures established with stromal
cell contact (Figure 4D). Both the F+KLS and Lin− BM subsets
produced progeny cells over 35 days in both“contact”and“no con-
tact” co-cultures. Co-cultures established with the most primitive
F−KLS HSC were only productive in contact with stroma and not
in the presence of a Transwell membrane.
Co-cultures established with each of the F−KLS and F+KLS
HSC subsets of BM in contact with stroma remained viable cell
producers for up to 35 days. Flow cytometric analysis of prog-
eny from both F−KLS and F+KLS co-cultures established with
5G3 contact displayed predominantly an L-DC phenotype as
CD11c+CD11b+MHC-II− cells after 28 days (Figure 5A). This
suggested that both the sorted F−KLS and F+KLS subsets must
contain L-DC progenitors. The L-DC population was gated strictly
on the basis of isotype controls which at early time points divided
a single population of CD11b+ cells with a mixed CD11c−/+ phe-
notype. While one could argue that this population should be
analyzed as one, further characterization has been deferred until
useful markers are identified.
In stromal contact co-cultures, transient production of
CD11b+CD11c+MHC-II+ cDC-like cells reached a peak at day
14 and then declined to be lost by 28–35 days (Figure 5B).
CD11c+CD11b+MHC-II+ cDC-like cells constituted only a maxi-
mum of ∼25% of cells produced at 14 days in F−KLS co-cultures,
compared with ∼70% in F+KLS co-cultures, and ∼85% in Lin−
BM co-cultures after 14 days (Figure 6B). A distinct MHC-IIhi
cDC-like cell population was also observed in F+KLS co-cultures
for up to 21 days (Figure 5B), and in Lin− BM co-cultures for
up to 35 days (Figure 5B). This population was evident in F−KLS
co-cultures by 14 days but was gone by 28 days (Figure 6A). In
addition to the outgrowth of cDC-like cells, an early transient
CD11b+CD11c−MHC-II− myeloid cell population was observed
at 7 and 14 days, probably arising from preformed myeloid
precursors (Figure 5A).
When contact between progenitors and stroma was prevented
with a Transwell membrane, no hematopoiesis was observed
for F-KLS co-cultures, and L-DC production which occurred in
contact cultures, was inhibited (Figure 5). Production of only
cDC-like cells and no L-DC was evident in F+KLS and Lin−BM
co-cultures. Transwell cultures of F+KLS and Lin−BM were able to
maintain production of cDC-like cells or“T-DC”for 35 days in the
FIGURE 4 | Establishment of productive 5G3 co-cultures with HSC. Lin−
BM was prepared using magnetic bead technology. Cells were then stained
with a lineage antibody cocktail and antibodies specific for CD11c, c-kit, Sca-1,
and Flt3 ahead of sorting to isolate HSC. (A) HSC were sorted as PI−Lin−
CD11c−c-kit+Sca-1+Flt3− cells (F−KLS), and PI−Lin−CD11c−c-kit+Sca-1+Flt3+
(F+KLS) cells. Gates were set using isotype controls, and numbers in gates
represent % positive cells. (B) Recovery of HSC subsets from BM in three
separate experiments. Data represent mean±SE. (C) Sorted HSC subsets
were co-cultured in contact with 5G3 stroma for up to 35 days, and
photographed at 28 days under phase contrast microscopy (Magnification
200x, bar 100µm). (D) % live cell recovery relative to total input cell number
was estimated at 7-day intervals for co-cultures established with Transwells
(no contact) and without Transwells (contact). Data represent mean±SE for
three replicate experiments.
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FIGURE 5 | HSC development in co-cultures. Co-cultures were
established by overlay of F−KLS or F+KLS subsets of HSC (sorted as in
Figure 4) over near-confluent 5G3 stroma, with or without a Transwell
membrane for a period of 35 days. Non-adherent cells collected at 7-day
intervals were assessed in terms of cell yield and cell surface phenotype.
(A) Cells were stained with fluorochrome-conjugated antibodies specific
for CD11c, CD11b, and MHC-II, or with isotype control antibodies. FSC and
SSC analysis was used to gate large cells for subsequent analysis. Isotype
control staining, shown as a gray density plot overlay, was used to set
gates indicating background binding. Numbers shown in quadrants
represent % positive cells. (B) The percent yield of live CD11c+CD11b
+MHC-II− (L-DC) and CD11c+CD11b+MHC-II+ (cDC-like) cells in co-cultures
was estimated relative to input cell number. Three replicate experiments
were assessed. Data represent mean±SE (n=3). By day 28, production
of L-DC was significantly greater than cDC-like cells (p≤0.05) for all
productive cultures.
absence of stromal cell contact suggesting that soluble factors pro-
duced by stroma must drive the production of cDC-like cells from
pre-existing precursors maintained within the F+KLS subset and
Lin−BM. Within the T-DC population, two subpopulations were
observed, differing in level of MHC-II expression. The MHC-IIhi
subpopulation disappeared after 28 days in Lin− BM co-cultures,
but remained to 35 days in F+KLS co-cultures (Figure 5A).
L-DC derived from both purified F−KLS and F+KLS subsets of
HSC were highly endocytic (>90% cells) (Figure 2C), as shown
previously for L-DC derived in Lin− BM co-cultures (Figure 2B).
T-DC were distinct, however, and only 35–40% of T-DC derived
from F+KLS and Lin− BM Transwell co-cultures were able to endo-
cytose FITC-OVA. L-DC showed significantly greater endocytic
capacity than T-DC (p< 0.01).
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FIGURE 6 | Influence of inflammatory signals on L-DC hematopoiesis.
Mutant mice were compared with wild type (WT) mice to determine whether
toll-like receptor (TLR) signaling or lymphoid cells are necessary to initiate
L-DC hematopoiesis. Co-cultures were established over near-confluent 5G3
stroma for 28 days by overlay of Lin− BM from individual mice: MyD88−/−
(n= 5),TRIF−/− (n= 4), MyD88−/−TRIF−/− (n=4), Rag1−/− (n=2), and from WT
C57BL/6J mice (n=5). (A) Percent live cell recovery relative to input cell
number was determined. Data represent mean±SE. At 21 days, yield from all
mutant co-cultures was significantly different from WT (p≤0.05). (B)
Non-adherent cells were collected at 14, 21, and 28 days and stained with
fluorochrome-conjugated antibodies specific for CD11c, CD11b, and MHC-II to
detect subsets of L-DC and cDC-like cells as described in Figure 5. The %
yield of live CD11c+CD11b+MHC-II− L-DC and CD11c+CD11b+MHC-II+ cDC-like
cells in co-cultures from individual mice was estimated relative to input cell
number using flow cytometric analysis. Data represent mean±SE. Data
points identified by * are significantly different (p<0.01) from WT.
HEMATOPOIESIS IN 5G3 CO-CULTURES IS NOT DRIVEN BY
INFLAMMATORY SIGNALS
One consideration with respect to hematopoiesis occurring in co-
cultures, is whether inflammatory events involving TLR signaling
support the production of L-DC and/or cDC-like cells. A cascade
of signaling reactions follows TLR binding by ligands, depen-
dent on the adaptor proteins MyD88 and TRIF. All TLR except
TLR3 require MyD88, and while TLR3 is dependent on TRIF,
TLR4 can utilize either MyD88 or TRIF adaptor proteins (O’Neill
and Bowie, 2007). Lin− BM cells from MyD88−/−, TRIF−/−, and
MyD88−/−TRIF−/− mice were assessed in relation to wild type
(WT) mice for capacity to undergo in vitro hematopoiesis in 5G3
co-cultures for L-DC production. Rag−/− mice which lack lym-
phoid cells, were also tested to determine the importance of mature
lymphoid cells, and any factors they produce, in the development
of L-DC progenitors.
In all Lin− BM co-cultures from mutant mice, there was con-
stant development and maintenance of cells above 5G3 stroma.
This was evident by total cell production assessed over 28 days of
co-culture (Figure 6A), and by microscopy (not shown). How-
ever the total cell production in WT co-cultures was highest, with
cell production in Rag−/− co-cultures equal to WT at 14 days, but
declining thereafter (Figure 6A). Each of the MyD88−/−,TRIF−/−,
and MyD88−/−TRIF−/− co-cultures showed significantly lower
production of cells (p< 0.01) compared with WT mice across
14–28 days of co-culture, suggesting a lower frequency of prog-
enitors, or lower ability of progenitors to undergo hematopoiesis.
The relative frequency of L-DC to cDC-like cells produced was
also assessed over 14–28 days to determine whether the relative fre-
quency of progenitors for the two subsets varied between mutant
and WT mice.
After cell production had stabilized after 28 days, WT,
MyD88−/−, and MyD88−/−TRIF−/− co-cultures produced only
L-DC (Figure 6B). This suggested that hematopoiesis of L-DC did
not depend on TLR signaling induced by pathogens or pathogen
products contaminating co-cultures. The production of L-DC
in TRIF−/− co-cultures was significantly lower than in WT co-
cultures at 28 days, suggesting that signaling through TRIF may
contribute to hematopoiesis. The effect of TRIF was however
partial, and since production in MyD88−/−TRIF−/− co-cultures
resembled WT, there appears to be a co-dependency between these
two molecules.
All WT and mutant co-cultures showed an initial outgrowth of
cDC-like cells that declined by 28 days (Figure 6B). Reduction in
numbers of cDC-like cells occurred across 14–28 days coinciding
with increased L-DC production, such that by 28 days the differ-
ence in the L-DC and cDC-like populations was large and signifi-
cant (p≤ 0.01) across all WT and mutant co-cultures (Figure 6B).
MyD88−/−TRIF−/−, MyD88−/−, and WT co-cultures showed
almost complete loss of the cDC-like population by 28 days
(Figure 6B). At 21 days, the proportion of cDC-like cells in
MyD88−/−, TRIF−/−, and MyD88−/−TRIF−/− mice was signif-
icantly less than in WT co-cultures such that production of cDC-
like cells could be to some extent dependent on inflammatory
signaling events involving TLR.
A small distinct population of CD11b+CD11c−MHC-II−
myeloid cells was observed in WT (∼20%) and TRIF−/− (∼15%)
co-cultures at 14 and 21 days but was absent in MyD88−/− and
MyD88−/−/TRIF−/− co-cultures (data not shown). Lin− BM
from MyD88−/− and MyD88−/−TRIF−/− mice may not contain
preformed myeloid cell precursors seen previously in co-culture
experiments in Figures 1 and 4. It is interesting to speculate
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that their development may be reliant on MyD88-dependent TLR
signaling.
Lin− BM isolated from Rag1−/−mice cultured over 5G3 stroma
gave a significantly lower yield of L-DC at days 21 and 28 com-
pared with WT co-cultures (Figure 6B). L-DC development may
therefore be influenced by lymphocytes, or their secreted factors.
A significant increase in the yield of cDC-like cells after 21 days in
Rag1−/− versus WT co-cultures begs an explanation in terms of
changes in precursor numbers within BM of Rag1−/− mice.
DISCUSSION
The most significant finding to come from this work is the impor-
tance of 5G3 stromal cell contact in the survival, maintenance,
and self-renewal of L-DC progenitors which can be isolated along
with known HSC subsets of BM. With the use of Transwell co-
cultures, it has been possible to distinguish the production of
L-DC from those of the cDC-like cells (also termed here “T-DC”),
only the latter developing in co-cultures when contact is restricted.
The best explanation for the development of cDC-like cells under
conditions of restricted contact is the preferential outgrowth of
these cells under conditions which support their development,
and clearly depends on contact with stroma, while cDC-like cell
development occurs preferentially in the absence of L-DC devel-
opment, supported by soluble factors. Development of cDC-like
cells is also transient and ceases by∼4 weeks, while production of
L-DC can be maintained for up to 12 months (Periasamy et al.,
2009; Hinton and O’Neill, 2011). L-DC are also shown here to be
distinct from cDC-like cells by their expression of Sirpα, a marker
common to macrophages and some DC subsets (Matozaki et al.,
2009). They are also distinct by their inability to respond to LPS
activation (Hinton and O’Neill, 2012). Indeed MHC-II expression
is not upregulated upon LPS treatment, a result consistent with the
inability of L-DC to activate CD4+ OT-II T cells in the presence
and absence of LPS.
Since 5G3 stroma has been reported to produce M-CSF but
not Flt3L or GM-CSF (Despars et al., 2004; O’Neill et al., 2004),
these dendritic-like cells are distinct from cDC and pDC which
develop in vitro from Flt3L-dependent precursors (Naik et al.,
2005). Development of L-DC is also not dependent on GM-CSF,
a factor that supports monocyte-derived (mo) DC development
in vitro (Caux et al., 1992; Xu et al., 1995). A role for M-CSF in
development of pDC and cDC from BM precursors has recently
been reported (Fancke et al., 2008). However since neither L-DC
or the cDC-like cells express CD115 (M-CSFR), they do not appear
to reflect myeloid cells or progenitors which respond to M-CSF,
although a role for M-CSF in development of L-DC and cDC-
like cells from progenitors cannot yet be ruled out. Overall, these
findings, along with phenotypic information, serve to distinguish
L-DC and the cDC-like subset (T-DC) as distinct, and also distinct
from known cDC, pDC, and moDC.
Another important finding is that the L-DC progenitor appears
to be maintained in co-cultures and may be self-renewing. It is
contained within both of the F−KLS and the F+KLS subsets of
HSC sorted from BM. The F+KLS but not the F−KLS subset also
contains precursors of cDC-like cells (or T-DC), which can differ-
entiate for up to 35 days in co-cultures in the absence of stromal
cell contact, apparently supported by soluble mediators. It is also
significant that L-DC progenitors are unable to survive for more
than 7 days in the absence of stromal cell contact. Since L-DC can
be derived from the Flt3− HSC subset in BM, they are further
distinguished from cDC and pDC which derive from the Flt3+
common dendritic progenitor (CDP) (Onai et al., 2007; Liu et al.,
2009), and from monocytes and cDC which derive from the Flt3+
myeloid dendritic progenitor (MDP) (Varol et al., 2007; Liu et al.,
2009).
The best interpretation of results obtained here is that L-DC
progenitors are present within both the F−KLS and F+KLS sub-
sets of HSC, and that Flt3 is not a determining marker for this
progenitor. A second explanation is that distinct but linked prog-
enitors may exist, such that the progenitor contained within the
F−KLS subset may differentiate upon stromal contact to give the L-
DC progenitor contained within the F+KLS subset, or vice versa.
Further marker analysis of these HSC subsets will be needed to
delineate L-DC progenitors more fully. The F+KLS subset of BM
HSC must contain both an L-DC progenitor and a precursor of
cDC-like cells. One issue requiring an explanation is why cDC-like
cells are lost over time in stromal contact co-cultures, where L-DC
predominate over time, while in the absence of stromal contact,
cDC-like cells prevail. Our prediction is that it could take∼2 weeks
for L-DC progenitors in the F−KLS and F+KLS subsets of HSC to
establish sustained contact with stroma leading to self-renewal.
Only once this occurs, may development become skewed toward
L-DC production. On the basis of Flt3 expression, the precursor of
cDC-like cells may be related to described subsets of CDP or MDP,
which are both precursors of cDC-like cells (Liu et al., 2009).
It has also been established that hematopoiesis leading to L-DC
development occurs independently of TLR signaling, and there-
fore independent of inflammatory events. This result supports our
hypothesis for spleen as a site for hematopoiesis in the steady-state
leading to the production of a tissue-specific APC, namely L-DC.
However, TLR signaling through MyD88 appears to determine the
outgrowth of a distinct CD11b+CD11c−MHC-II− myeloid cell
population in co-cultures involving the less pure population of
Lin− BM. This population is however transient, probably arising
from a preformed myeloid precursor which develops in response to
inflammation. The L-DC progenitor is quite distinct as a renewable
progenitor, and its development is independent of TLR signaling.
MyD88−/− and MyD88−/−TRIF−/− mice may therefore provide
a better BM source of L-DC progenitors due to the absence of
myelopoiesis induced by inflammation and TLR signaling. These
could be utilized to benefit in future developmental studies.
The hallmark of DC is their unique ability to cross-present
antigen to CD8+ T cells via the exogenous MHC-I pathway. Both
L-DC and T-DC show capacity for cross-presentation of antigen
to CD8+ T cells, activating them and inducing their prolifera-
tion. Further experiments are however underway to investigate
the exact pathways for antigen processing by these distinct APCs.
As cross-presenting cells, T-DC as MHC-II+ cells, resemble moDC
or cDC (Belz et al., 2004; Dominguez and Ardavin, 2010). How-
ever, the absence of CD8α expression on T-DC (Periasamy and
O’Neill, 2013) precludes their relationship with CD8α+ cDC (Naik
et al., 2006), and their expression of CD11b precludes any simi-
larity with the precursors of CD8α+ cDC, which are described as
CD8α−CD11b− cells (Bedoui et al., 2009).
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In terms of antigen presentation to CD4+ T cells, L-DC and
T-DC differ significantly. L-DC are unable to activate or induce
proliferation of CD4+ T cells, while T-DC can activate CD4+ T
cells, but not induce their proliferation. T cell activation and pro-
liferation was not inducible with LPS treatment of T-DC, nor
was it due to weak or absent MHC-II expression, since T-DC
did induce antigen-specific activation of OT-II T cells. The T-DC
subset described here is therefore also distinct as a cDC-like sub-
set. One consideration is that these cells are an aberrant cell type
induced by in vitro differentiation. Another is that they reflect a
cDC-like or moDC-like cell which is immature, non-responsive
to LPS, and non-immunogenic. Its classification as a tolerogenic
or regulatory DC is possible, and is under further investigation.
This would be consistent with the findings of others that regu-
latory DC can be derived by in vitro culture of progenitors from
BM above stroma, although former studies did not use such pure
populations of progenitors nor did they investigate the same T cell
activation properties of regulatory DC produced (Svensson et al.,
2004; Zhang et al., 2004; Tang et al., 2006). Notably, none of those
former studies reported the production of L-DC.
Spleen is a known site for extramedullary hematopoiesis and a
rescue niche for hematopoiesis when BM is compromised. HSC
have been identified in resting spleen, albeit in lower numbers
than in BM (Wolber et al., 2002; Dor et al., 2006; Tan and
O’Neill, 2010). Here we confirm that spleen stroma can sup-
port myelopoiesis in vitro from HSC with continuous produc-
tion of a novel dendritic-like “L-DC” reflecting tissue-specific
hematopoiesis. Consistent with this finding is evidence that the
in vivo equivalent of this novel cell type can also be identified
amongst resting splenic myeloid and DC subsets in normal mice,
and it is not present in other organs (Tan et al., 2011). This novel
in vivo subset parallels in terms of phenotype and function, with
cells generated in vitro both in LT spleen cultures (Quah et al.,
2004) and in co-cultures of HSC over stroma as shown here.
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